283 related articles for article (PubMed ID: 29506828)
1. Effect of the vascularized bone components on the survival of vascularized composite allografts.
Chen J; Zhang D; Zhang T; Chen C; Song Y; Liu S; Su Y; Guo S
J Surg Res; 2018 Apr; 224():132-138. PubMed ID: 29506828
[TBL] [Abstract][Full Text] [Related]
2. A novel rat full-thickness hemi-abdominal wall/hindlimb osteomyocutaneous combined flap: influence of allograft mass and vascularized bone marrow content on vascularized composite allograft survival.
Ramirez AE; Cheng HY; Lao WW; Wang YL; Wen CJ; Wallace CG; Lin CF; Shih LY; Chuang SH; Wei FC
Transpl Int; 2014 Sep; 27(9):977-86. PubMed ID: 24861714
[TBL] [Abstract][Full Text] [Related]
3. The reversed paradigm of chimerism induction: Donor conditioning with recipient-derived bone marrow cells as a novel approach for tolerance induction in vascularized composite allotransplantation.
Siemionow M; Rampazzo A; Gharb BB; Cwykiel J; Klimczak A; Madajka M; Nasir S; Bozkurt M
Microsurgery; 2016 Nov; 36(8):676-683. PubMed ID: 26990895
[TBL] [Abstract][Full Text] [Related]
4. Vascularized bone grafts within composite tissue allotransplants can autocreate tolerance through mixed chimerism with partial myeloablative conditioning: an experimental study in rats.
Huang WC; Lin JY; Wallace CG; Chuang WY; Wei FC; Liao SK
Plast Reconstr Surg; 2010 Apr; 125(4):1095-1103. PubMed ID: 20072086
[TBL] [Abstract][Full Text] [Related]
5. Donor Recipient Chimeric Cells Induce Chimerism and Extend Survival of Vascularized Composite Allografts.
Cwykiel J; Jundzill A; Klimczak A; Madajka-Niemeyer M; Siemionow M
Arch Immunol Ther Exp (Warsz); 2021 May; 69(1):13. PubMed ID: 33970329
[TBL] [Abstract][Full Text] [Related]
6. Mesenchymal stem cells enhance the induction of mixed chimerism and tolerance to rat hind-limb allografts after bone marrow transplantation.
Pan H; Zhao K; Wang L; Zheng Y; Zhang G; Mai H; Han Y; Yang L; Guo S
J Surg Res; 2010 May; 160(2):315-24. PubMed ID: 19524257
[TBL] [Abstract][Full Text] [Related]
7. Trafficking of donor-derived bone marrow correlates with chimerism and extension of composite allograft survival across MHC barrier.
Ozmen S; Ulusal BG; Ulusal AE; Izycki D; Yoder B; Siemionow M
Transplant Proc; 2006 Jun; 38(5):1625-33. PubMed ID: 16797371
[TBL] [Abstract][Full Text] [Related]
8. Combined treatment with regulatory T cells and vascularized bone marrow transplantation creates mixed chimerism and induces donor-specific tolerance to vascularized composite allografts without cytoreductive conditioning.
Lin JY; Tsai FC; Wallace CG; Huang WC; Wei FC; Liao SK
J Surg Res; 2012 Dec; 178(2):974-81. PubMed ID: 22819314
[TBL] [Abstract][Full Text] [Related]
9. A clinically feasible approach to induce delayed tolerance in recipients of prior kidney or vascularized composite allotransplants.
Chen B; Xu H; Corbin DR; Ildstad ST
Transplantation; 2012 Oct; 94(7):671-8. PubMed ID: 22948444
[TBL] [Abstract][Full Text] [Related]
10. Neonatal induction of tolerance to skeletal tissue allografts without immunosuppression.
Butler PE; Lee WP; van de Water AP; Randolph MA
Plast Reconstr Surg; 2000 Jun; 105(7):2424-30; discussion 2431-2. PubMed ID: 10845297
[TBL] [Abstract][Full Text] [Related]
11. Toward Development of the Delayed Tolerance Induction Protocol for Vascularized Composite Allografts in Nonhuman Primates.
Lellouch AG; Ng ZY; Rosales IA; Schol IM; Leonard DA; Gama AR; Colvin RB; Lantieri LA; Randolph MA; Cetrulo CL
Plast Reconstr Surg; 2020 Apr; 145(4):757e-768e. PubMed ID: 32221215
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous bone marrow and composite tissue transplantation in rats treated with nonmyeloablative conditioning promotes tolerance.
Xu H; Ramsey DM; Wu S; Bozulic LD; Ildstad ST
Transplantation; 2013 Jan; 95(2):301-8. PubMed ID: 23250336
[TBL] [Abstract][Full Text] [Related]
13. New composite tissue allograft model of vascularized bone marrow transplant: the iliac osteomyocutaneous flap.
Nasir S; Klimczak A; Sonmez E; Bozkurt M; Gibson S; Siemionow M
Transpl Int; 2010 Jan; 23(1):90-100. PubMed ID: 19686290
[TBL] [Abstract][Full Text] [Related]
14. The Influence of Timing and Frequency of Adipose-Derived Mesenchymal Stem Cell Therapy on Immunomodulation Outcomes After Vascularized Composite Allotransplantation.
Plock JA; Schnider JT; Schweizer R; Zhang W; Tsuji W; Waldner M; Solari MG; Marra KG; Rubin JP; Gorantla VS
Transplantation; 2017 Jan; 101(1):e1-e11. PubMed ID: 27893612
[TBL] [Abstract][Full Text] [Related]
15. Adipose- and Bone Marrow-Derived Mesenchymal Stem Cells Prolong Graft Survival in Vascularized Composite Allotransplantation.
Plock JA; Schnider JT; Zhang W; Schweizer R; Tsuji W; Kostereva N; Fanzio PM; Ravuri S; Solari MG; Cheng HY; Rubin PJ; Marra KG; Gorantla VS
Transplantation; 2015 Sep; 99(9):1765-73. PubMed ID: 26102613
[TBL] [Abstract][Full Text] [Related]
16. Long-term survival of composite hemiface/mandible/tongue allografts correlates with multilineage chimerism development in the lymphoid and myeloid compartments of recipients.
Kulahci Y; Klimczak A; Madajka M; Altuntas S; Siemionow M
Transplantation; 2010 Oct; 90(8):843-52. PubMed ID: 20697324
[TBL] [Abstract][Full Text] [Related]
17. An alternative model of vascularized bone marrow transplant: partial femur transplantation.
Chen JW; Chen C; Su YJ; Yan L; Wang SP; Guo SZ
Ann Plast Surg; 2014 Dec; 73(6):710-5. PubMed ID: 24830660
[TBL] [Abstract][Full Text] [Related]
18. Combined treatment with regulatory T cells and vascularized bone marrow transplantation creates mixed chimerism and induces donor-specific tolerance to vascularized composite allografts without cytoreductive conditioning.
Lin JY; Tsai FC; Wallace CG; Huang WC; Wei FC; Liao SK
Chimerism; 2013; 4(1):20-2. PubMed ID: 23712382
[TBL] [Abstract][Full Text] [Related]
19. Immunomodulatory Effects of Different Cellular Therapies of Bone Marrow Origin on Chimerism Induction and Maintenance Across MHC Barriers in a Face Allotransplantation Model.
Hivelin M; Klimczak A; Cwykiel J; Sonmez E; Nasir S; Gatherwright J; Siemionow M
Arch Immunol Ther Exp (Warsz); 2016 Aug; 64(4):299-310. PubMed ID: 26708158
[TBL] [Abstract][Full Text] [Related]
20. Optimizing chimerism level through bone marrow transplantation and irradiation to induce long-term tolerance to composite tissue allotransplantation.
Lin JY; Tsai FC; Wallace CG; Huang WC; Wei FC; Liao SK
J Surg Res; 2012 Nov; 178(1):487-93. PubMed ID: 22484382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
